Indian stocks: Visit www.stage2stocks.com →

GoodRx Holdings, Inc. Class A

Stage 2 · Advancing · week 14

As of Oct 22, 2026, GoodRx Holdings is in Stage 2, the uptrend phase, now in week 14 (since Jul 16, 2026). It closed at $3.62, 8.4% below its 52-week high and above its 200-day average, which is rising.

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. More about the company

$3.62
-1.61% today
$1.2B · Small cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 16 in Health Information Services · #1 of 272 in Health Care

Is GDRX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 31w
S4 16w
S4 35w
S2 14w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 6w → S3 4w → S4 7w → S1 5w → S2 31w → S3 8w → S4 16w → S1 7w → S4 12w → S1 7w → S2 2w → S3 1w → S4 35w → S1 10w → S2 14w current
Total tracked: 166 weeks across 15 stage runs.

GDRX among Health Information Services14th of 41 by relative strength

All 41 →
Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AMWLStage 2 · wk 2597+7.4%
2HNGEStage 2 · wk 2096+19.1%
3BTSGStage 3 · wk 894+9.1%
4NRCStage 3 · wk 493−0.1%
5SOPHStage 2 · wk 2491−12.7%
6HTFLStage 2 · wk 1087+17.0%
7HSTMStage 2 · wk 1777+20.3%
8OMCLStage 4 · wk 1070+12.5%
…14GDRXStage 2 · wk 1448+9.0%
vs 52W High
-8.4%
$1.87 lo$3.95 hi
8.4% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 14
1w13w26w
Week 14, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
29.3%
200 DMA: $2.80 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.61x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+9.0%
3M
+22.3%
6M
+57.4%
YTD
+31.6%
1Y
-6.9%
Scan Membership
Breakout Watch
Latest: 2024-01-19
4 appearances in last 60 days. First seen: 2021-10-14.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 14 · Vol 0.61x
2026-10-21S2
Wk 14 · Vol 1.19x
2026-10-20S2
Wk 14 · Vol 2.00x
2026-10-19S2
Wk 14 · Vol 0.81x
2026-10-16S2
Wk 14 · Vol 0.66x
2026-10-15S2
Wk 13 · Vol 1.48x
2026-10-14S2
Wk 13 · Vol 0.51x
2026-10-13S2
Wk 13 · Vol 0.55x
2026-10-12S2
Wk 13 · Vol 0.61x
2026-10-09S2
Wk 13 · Vol 0.45x
2026-10-08S2
Wk 12 · Vol 0.78x
2026-10-07S2
Wk 12 · Vol 0.40x
Moving averages & range
50 DMA
$3.45
200 DMA
$2.80
52W High
$3.95
52W Low
$1.87
5D Low
$3.36
Resistance levels (recent highs)
20d High
$3.68
60d High
$3.80
120d High
$3.80
250d High
$3.95
Next resistance
+1.6%
to 20d High
P/E (TTM)
72.4
Forward 10.3
Earnings Growth (YoY)
-44.5%
Revenue -1.3%
ROE
+2.5%
Profit margin +2.1%
Dividend Yield
0.00%
P/B 1.9

GoodRx Holdings: quick answers

What stage is GoodRx Holdings in?

As of Oct 22, 2026, GoodRx Holdings (GDRX) is in Stage 2, the uptrend phase. It entered Stage 2 on Jul 16, 2026 and is in week 14. What the four stages mean

Is GoodRx Holdings in an uptrend?

Yes. GoodRx Holdings is in a Stage 2 uptrend. It trades 29.3% above its 200-day average, which is rising.

How far is GoodRx Holdings from its 52-week high?

GoodRx Holdings closed at $3.62 on Oct 22, 2026, 8.4% below its 52-week high of $3.95. Its 52-week low is $1.87.

How has GoodRx Holdings performed over the past year?

As of Oct 22, 2026, GoodRx Holdings is down 6.9% over the past year and up 31.6% so far in 2026.

Which sector and industry is GoodRx Holdings in?

GoodRx Holdings is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.